KINTOR PHARMA-B 09939·

Gross margin ----1.29%----------100.00%-----------94.60%--24.60%119.20% Net margin -----15542.12%-----------2460.04%-----------3105.84%---612.29%2493.55% ROE -----43.10%---62.92%19.81%-----50.88%---63.83%12.95%-231.56%167.73%-52.81%178.76%-109.59%56.78% ROA -----25.61%---42.03%16.42%-----40.72%---46.44%5.72%-122.04%75.60%-30.15%91.89%-58.72%28.57% Revenue growth ---------100.00%----------------------553.64%-- Attributable profit growth ---------114.39%-----------13.33%---11.15%2.18%85.36%96.52%-28.86%114.22% Debt-to-assets ----40.59%--33.20%7.39%----19.96%--27.25%7.28%47.30%20.05%42.91%4.39%46.42%3.51% Current ratio ----2.01--1.550.47----6.94--4.742.202.102.641.031.070.430.60 Operating cash flow / net profit ----1.06--0.980.08----1.25--1.010.240.370.641.280.920.850.43 Operating cash flow / revenue -----16456.73%-----------3071.38%-----------3981.60%---519.36%3462.24%

Gross margin -3.28%--49.32%52.59% Net margin -1391.51%---145.62%1245.89% Revenue growth ----769.65%-- Attributable profit growth ----8.99%-- Debt-to-assets ----65.75%-- Current ratio ----0.26-- Operating cash flow / net profit 0.83--0.670.17 Operating cash flow / revenue -1161.78%---97.41%1064.37%

Revenue ----698.00K--0100.00%----34.23M----------5.00M--32.68M553.64% Other income and gains ----12.30M--19.02M54.64%----29.31M--18.61M36.50%20.87M12.12%21.95M5.18%2.33M89.41% Cost of sales ----689.00K--0100.00%------------------------ Gross profit ----9.00K--0100.00%----34.23M-------42.23M---4.73M88.80%8.04M269.96% Selling and distribution expenses ----0--336.00K------14.70M--20.33M38.29%6.98M65.64%26.56M280.27%41.17M55.00% Administrative expenses ----24.10M--32.76M35.92%----103.25M--132.25M28.08%89.05M32.67%61.83M30.57%82.07M32.75% Net finance costs ----4.01M--3.89M2.92%----2.49M--8.19M228.27%9.69M18.36%9.28M4.26%3.94M57.49% Income tax ----0--0----------1.08M--8.04M641.11%18.00K99.78%2.85M15744.44% Operating profit -----104.48M---228.69M118.89%-----839.60M---944.53M12.50%-1.06B12.14%-144.57M86.35%-199.78M38.19% Share of associates and JVs ---------------------568.00K--52.00K109.15%-1.43M2848.08%766.00K153.60% Profit before tax -----108.48M---232.58M114.39%-----842.10M---953.28M13.20%-1.07B12.12%-155.27M85.47%-202.96M30.71% Net profit -----108.48M---232.58M114.39%-----842.10M---954.37M13.33%-1.06B11.15%-155.29M85.36%-200.11M28.86% Net profit attributable to owners -----108.48M---232.58M114.39%-----842.10M---954.37M13.33%-1.06B11.15%-155.29M85.36%-200.11M28.86%

Revenue 5.98M--52.04M769.65% Other income and gains 1.25M--617.00K50.80% Cost of sales 6.18M--26.38M326.78% Gross profit -196.00K--25.66M13194.39% Selling and distribution expenses 8.27M--57.52M595.19% Administrative expenses 25.23M--22.31M11.58% Net finance costs 2.24M--2.08M6.84% Income tax 277.00K--3.02M991.34% Operating profit -80.83M---81.32M0.61% Share of associates and JVs -481.00K--4.60M1056.34% Profit before tax -83.55M---78.81M5.67% Net profit -83.27M---75.78M8.99%

Cash and cash equivalents ----137.51M--195.53M42.19%----930.15M--865.08M7.00%445.50M48.50%147.42M66.91%32.74M77.79% Trade and bills receivables ----------------------------21.66M--7.26M66.49% Inventories ----------------351.36M--603.50M71.76%----2.21M--12.09M445.91% Total current assets ----218.34M--220.61M1.04%----1.53B--1.51B1.18%472.56M68.66%171.73M63.66%55.25M67.83% Total assets ----423.60M--553.38M30.64%----2.07B--2.06B0.62%869.23M57.70%515.13M40.74%340.81M33.84% Total current liabilities ----108.39M--142.58M31.55%----219.74M--318.13M44.77%224.73M29.36%166.68M25.83%127.58M23.46% Total liabilities ----171.92M--183.71M6.86%----412.83M--559.95M35.64%411.12M26.58%221.05M46.23%158.21M28.43% Equity attributable to owners ----251.68M--369.66M46.88%----1.66B--1.50B9.66%458.11M69.36%294.08M35.81%182.60M37.91% Total equity ----251.68M--369.66M46.88%----1.66B--1.50B9.66%458.11M69.36%294.08M35.81%182.60M37.91%

Cash and cash equivalents ----31.30M-- Trade and bills receivables ----4.36M-- Inventories ----11.01M-- Total current assets ----48.29M-- Total assets ----318.94M-- Total current liabilities ----182.93M-- Total liabilities ----209.72M-- Equity attributable to owners ----109.22M-- Total equity ----109.22M--

Net cash from operating activities -----114.87M---228.04M98.53%-----1.05B---961.26M8.57%-387.58M59.68%-199.08M48.64%-169.74M14.74% Net cash from investing activities -----64.75M---7.01M89.17%----92.00M--67.19M26.97%3.27M95.13%20.03M511.91%14.41M28.07% Net cash from financing activities ----303.94M--295.85M2.66%----857.42M--815.75M4.86%-33.46M104.10%-119.67M257.62%40.27M133.65% Net change in cash ----124.32M--60.80M51.10%-----101.94M---78.31M23.18%-417.77M433.45%-298.72M28.50%-115.06M61.48%

Net cash from operating activities -69.52M---50.69M27.08% Net cash from investing activities 14.73M--316.00K97.86% Net cash from financing activities -40.06M--48.97M222.25% Net change in cash -94.85M---1.41M98.51%